BRPI0719228A2 - Composição estabilizada de prostaglandina e - Google Patents
Composição estabilizada de prostaglandina eInfo
- Publication number
- BRPI0719228A2 BRPI0719228A2 BRPI0719228-2A2A BRPI0719228A BRPI0719228A2 BR PI0719228 A2 BRPI0719228 A2 BR PI0719228A2 BR PI0719228 A BRPI0719228 A BR PI0719228A BR PI0719228 A2 BRPI0719228 A2 BR PI0719228A2
- Authority
- BR
- Brazil
- Prior art keywords
- prostaglandine
- stabilized composition
- stabilized
- composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Inorganic Chemistry (AREA)
- Reproductive Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Gynecology & Obstetrics (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/546,196 US7560489B2 (en) | 2006-10-11 | 2006-10-11 | Stabilized prostaglandin E composition |
PCT/US2007/021374 WO2008045309A1 (en) | 2006-10-11 | 2007-10-05 | Stabilized prostaglandin e composition |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0719228A2 true BRPI0719228A2 (pt) | 2015-02-03 |
Family
ID=39283156
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0719228-2A2A BRPI0719228A2 (pt) | 2006-10-11 | 2007-10-05 | Composição estabilizada de prostaglandina e |
Country Status (12)
Country | Link |
---|---|
US (1) | US7560489B2 (pt) |
EP (1) | EP2073634A4 (pt) |
JP (1) | JP5382800B2 (pt) |
KR (1) | KR101400359B1 (pt) |
AU (1) | AU2007307136B2 (pt) |
BR (1) | BRPI0719228A2 (pt) |
CA (1) | CA2665611C (pt) |
IL (1) | IL197885A (pt) |
MX (1) | MX2009003794A (pt) |
NZ (1) | NZ576242A (pt) |
WO (1) | WO2008045309A1 (pt) |
ZA (1) | ZA200902467B (pt) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7560489B2 (en) * | 2006-10-11 | 2009-07-14 | Nexmed Holdings, Inc. | Stabilized prostaglandin E composition |
WO2010039251A1 (en) * | 2008-10-03 | 2010-04-08 | Nexmed Holdings, Inc. | Stabilized composition for treating psoriasis |
AU2010256558B2 (en) | 2009-06-03 | 2013-10-03 | Forsight Labs, Llc | Anterior segment drug delivery |
CN102858158A (zh) | 2010-05-04 | 2013-01-02 | 尼克美控股公司 | 小分子治疗剂的组合物 |
US20130209393A1 (en) * | 2010-05-04 | 2013-08-15 | Nexmed Holdings, Inc. | Therapeutic peptide compositions and methods |
CA2745320A1 (en) * | 2011-07-06 | 2013-01-06 | Duoject Medical Systems Inc. | Reconstitution device |
CN103917202B (zh) | 2011-09-14 | 2016-06-29 | 弗赛特影像5股份有限公司 | 眼***件装置和方法 |
US9750636B2 (en) | 2012-10-26 | 2017-09-05 | Forsight Vision5, Inc. | Ophthalmic system for sustained release of drug to eye |
EP3283004A4 (en) | 2015-04-13 | 2018-12-05 | Forsight Vision5, Inc. | Ocular insert composition of semi-crystalline or crystalline pharmaceutically active agent |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4036954A (en) * | 1973-11-02 | 1977-07-19 | Yamanouchi Pharmaceutical Co., Ltd. | Stable prostaglandin E group-containing formulation |
US4113882A (en) * | 1974-10-21 | 1978-09-12 | Yamanouchi Pharmaceutical Co., Ltd. | Stabilized oral prostaglandin formulation and the process for the preparation thereof |
JPS5770816A (en) * | 1980-10-17 | 1982-05-01 | Ono Pharmaceut Co Ltd | Multilayered film preparation of prostagladin of prolonged action |
JPS58134019A (ja) * | 1982-02-05 | 1983-08-10 | Ono Pharmaceut Co Ltd | プロスタグランジン含有持続放出型三層状フイルム製剤及びその製造方法 |
US4806354A (en) * | 1984-04-06 | 1989-02-21 | Green James P | Health food composition |
US5525348A (en) * | 1989-11-02 | 1996-06-11 | Sts Biopolymers, Inc. | Coating compositions comprising pharmaceutical agents |
CA2071137A1 (en) * | 1991-07-10 | 1993-01-11 | Clarence C. Lee | Composition and method for revitalizing scar tissue |
US6414028B1 (en) * | 1997-11-05 | 2002-07-02 | Nexmed Holdings, Inc. | Topical compositions containing prostaglandin E1 |
US6046244A (en) * | 1997-11-05 | 2000-04-04 | Nexmed Holdings, Inc. | Topical compositions for prostaglandin E1 delivery |
US5942545A (en) * | 1998-06-15 | 1999-08-24 | Macrochem Corporation | Composition and method for treating penile erectile dysfunction |
US6825234B2 (en) * | 1998-12-10 | 2004-11-30 | Nexmed (Holdings) , Inc. | Compositions and methods for amelioration of human female sexual dysfunction |
US6693135B2 (en) * | 2000-01-10 | 2004-02-17 | Nexmed (Holdings) Incorporated | Prostaglandin compositions and methods of treatment for male erectile dysfunction |
US20040110843A1 (en) * | 2000-01-10 | 2004-06-10 | Nexmed (Holdings), Inc. | Methods of treatment of male erectile dysfunction |
GB2372213B (en) * | 2000-11-17 | 2003-07-16 | Icebella Enterpises Ltd | Applicator and stimulator device |
US20050181030A1 (en) * | 2003-01-03 | 2005-08-18 | Mo Y. J. | Topical stabilized prostaglandin E compound dosage forms |
US6841574B2 (en) * | 2003-01-03 | 2005-01-11 | Nexmed Holdings, Inc. | Topical stabilized prostaglandin E compound dosage forms |
DE602004007315D1 (de) * | 2003-03-03 | 2007-08-16 | Personnes A Responsibilite Lim | Stabilisierte pharmazeutische Zusammensetzung enthaltend einen NSAID und einen Prostaglandin |
AR043476A1 (es) * | 2004-09-09 | 2005-08-03 | Dvoskin Victor Oscar | Dispositivo de administracion regulada de sustancias para la insercion en una cavidad corporal y procedimiento para fabricar un medio de soporte de dichas sustancias |
US7560489B2 (en) * | 2006-10-11 | 2009-07-14 | Nexmed Holdings, Inc. | Stabilized prostaglandin E composition |
-
2006
- 2006-10-11 US US11/546,196 patent/US7560489B2/en active Active
-
2007
- 2007-10-05 CA CA2665611A patent/CA2665611C/en not_active Expired - Fee Related
- 2007-10-05 BR BRPI0719228-2A2A patent/BRPI0719228A2/pt not_active Application Discontinuation
- 2007-10-05 WO PCT/US2007/021374 patent/WO2008045309A1/en active Application Filing
- 2007-10-05 EP EP07839278A patent/EP2073634A4/en not_active Withdrawn
- 2007-10-05 JP JP2009532364A patent/JP5382800B2/ja not_active Expired - Fee Related
- 2007-10-05 AU AU2007307136A patent/AU2007307136B2/en not_active Ceased
- 2007-10-05 KR KR1020097008945A patent/KR101400359B1/ko not_active IP Right Cessation
- 2007-10-05 MX MX2009003794A patent/MX2009003794A/es active IP Right Grant
- 2007-10-05 NZ NZ576242A patent/NZ576242A/en not_active IP Right Cessation
-
2009
- 2009-04-05 IL IL197885A patent/IL197885A/en not_active IP Right Cessation
- 2009-04-08 ZA ZA200902467A patent/ZA200902467B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
US20080090911A1 (en) | 2008-04-17 |
JP5382800B2 (ja) | 2014-01-08 |
KR101400359B1 (ko) | 2014-06-19 |
EP2073634A4 (en) | 2012-12-19 |
JP2010506831A (ja) | 2010-03-04 |
ZA200902467B (en) | 2010-03-31 |
EP2073634A1 (en) | 2009-07-01 |
CA2665611A1 (en) | 2008-04-17 |
AU2007307136B2 (en) | 2013-12-05 |
CA2665611C (en) | 2014-11-25 |
IL197885A0 (en) | 2009-12-24 |
KR20090064597A (ko) | 2009-06-19 |
MX2009003794A (es) | 2009-04-24 |
AU2007307136A1 (en) | 2008-04-17 |
WO2008045309A1 (en) | 2008-04-17 |
NZ576242A (en) | 2012-04-27 |
IL197885A (en) | 2016-04-21 |
US7560489B2 (en) | 2009-07-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DOP2007000084A (es) | Derivados de dihidropirazolopirimidinona | |
BRPI0906980A2 (pt) | Composição de derivados e maleatados | |
ATE528296T1 (de) | Polymorphe form von 4-ä3-(4- cyclopropancarbonylpiperazin-1-carbonyl)-4- fluorbenzylü-2h-phthalazin-1-on | |
ATE531720T1 (de) | Aza-benzofuranylverbindungen und anwendungsverfahren dafür | |
BRPI0716325A2 (pt) | Composição antimicrobianas | |
FR2899479B1 (fr) | Composition cicatrisante | |
BRPI0715712A2 (pt) | Composição farmacêutica | |
DK3136030T3 (da) | Fremgangsmåde til lyofilisering | |
DK2120592T3 (da) | Dairy compositions and method of making | |
NO20084339L (no) | Stabiliserte polypeptidsammensetninger | |
FR2908130B1 (fr) | Flottage de vitroceramique | |
BRPI0810179A2 (pt) | Composições de oligo-guluronato e galacturonato | |
BRPI0716147A2 (pt) | modificaÇço dinÂmica de propriedades de vÍdeo | |
BRPI0719393A2 (pt) | Composição farmacêutica | |
BRPI0719228A2 (pt) | Composição estabilizada de prostaglandina e | |
CR10562A (es) | Nuevos derivados de piridazina | |
BRPI0716445A2 (pt) | composiÇço farmacÊutica | |
BRPI0720234A2 (pt) | Composição farmacêutica | |
BRPI0716458A2 (pt) | Composição de vulcanizado | |
NO20055643D0 (no) | Preparation of lodixanol | |
BRPI0918206A2 (pt) | derivados de animoéster e composição medicinal destes | |
CR10809A (es) | Derivados de heteroaril-pirrolidinil-y-piperidinil-cetona | |
BRPI0817332A2 (pt) | Composição e método de ingrediente sensível estabilizado. | |
FI20065834A0 (fi) | Iskulaite | |
FR2896414B1 (fr) | Composition cosmetique matifiante |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B25A | Requested transfer of rights approved |
Owner name: FERRING INTERNATIONAL CENTER S.A. (CH) |
|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
B15K | Others concerning applications: alteration of classification |
Free format text: AS CLASSIFICACOES ANTERIORES ERAM: A01N 37/08 , A01N 53/00 , A61K 31/19 Ipc: A61K 31/5575 (2000.01), A61K 31/557 (1980.01), A61 |
|
B11B | Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements |